Zafer Cetin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zafer Cetin has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Eyup Ilker Saygili
School of Medicine, SANKO University
4 shared publications - Abdullah Erdogan
Department of Urology, University of Health Sciences, Bursa City Hospital, Bursa, Türkiye
1 shared publication - Ahmet Sarper Bozkurt
Gaziantep University
1 shared publication - Alexandros G. Georgakilas
DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Zografou Campus, 15780 Athens, Greece
1 shared publication - Athanasia Pavlopoulou
Dokuz Eylul University
1 shared publication Banu Guzel Nur
Department of Pediatric Genetics Faculty of Medicine Akdeniz University Antalya Turkey
1 shared publication
Latest Publications
- 12 December 2024
- Published by Springer Nature
- p. 123-152
Nutraceuticals in Metabolic Syndrome and Diabetes
- 12 December 2024
- Published by Springer Nature
- p. 123-152
Nutraceuticals in Metabolic Syndrome and Diabetes
- 15 December 2022
- Published by Canakkale Onsekiz Mart University in Journal of Advanced Research in Natural and Applied Sciences
- Vol. 8 (4) , 796-804
The Changes in Biochemical Compositions of Five Different Macroalgae and Seagrass (Halophila stipulacea (Forsskal) Ascherson 1867) Collected from Iskenderun Bay
In present study, biochemical compositions (ash, lipid and protein) of five different macroalgae ((Green Macroalgae-GMA (Chaetomorpha linum and Caulerpa prolifera), Red Macroalgae-RMA (Pterocladiella capi-lacea), Brown Macroalgae-BMA (Sargassum vulgare and Ericaria amentacea)) and Angiosperm/Seagrass (Hal-ophila stipulacea) collected from Iskenderun Bay were investigated. The differences observed between biochemical compositions such as ash, lipid and protein of five macroalgae species and Angiosperm/Seagrass (Halophila stip-ulacea) were statistically significant (p<0.05). The lowest and highest ash, lipid and protein values of five macroalgae were 12.19±1.15% (Caulerpa prolifera)- 21.38±1.53% (Ericaria amentacea), 1.74±0.19% (Caulerpa prolifera)- 5.83±0.68% (Ericaria amentacea), 5.56±0.06% (Chaetomorpha linum)- 11.45±0.53% (Sargassum vulgare), respec-tively. Ash, lipid and protein values of Angiosperms/Seagrass (Halophila stipulacea) were determined as 14.56±2.08%, 3.16±0.48% and 8.11±0.07%, respectively. Protein value of Angiosperms/Seagrass (Halophila stipulacea) was higher than those of (GMA (Chaetomorpha linum and Caulerpa prolifera) but not RMA(Pterocladiella capillacea) and BMA (Sargassum vulgare and Ericaria amentacea)). Lipid value of Angio-sperms/Seagrass (Halophila stipulacea) was similar to RMA(Pterocladiella capillacea). In conclusion, the information of the biochemical compositions of five different macroalgae and Angiosperms/Seagrass (Halophila stipulacea) are important for the evaluation of potential sources for commercial and human consumption. In addition, biochemical compositions of tested macroalgae and seagrass could make important contributions to feed formulations and functional foods in future.
- 15 December 2022
- Published by Canakkale Onsekiz Mart University in Journal of Advanced Research in Natural and Applied Sciences
- Vol. 8 (4) , 796-804
The Changes in Biochemical Compositions of Five Different Macroalgae and Seagrass (Halophila stipulacea (Forsskal) Ascherson 1867) Collected from Iskenderun Bay
In present study, biochemical compositions (ash, lipid and protein) of five different macroalgae ((Green Macroalgae-GMA (Chaetomorpha linum and Caulerpa prolifera), Red Macroalgae-RMA (Pterocladiella capi-lacea), Brown Macroalgae-BMA (Sargassum vulgare and Ericaria amentacea)) and Angiosperm/Seagrass (Hal-ophila stipulacea) collected from Iskenderun Bay were investigated. The differences observed between biochemical compositions such as ash, lipid and protein of five macroalgae species and Angiosperm/Seagrass (Halophila stip-ulacea) were statistically significant (p<0.05). The lowest and highest ash, lipid and protein values of five macroalgae were 12.19±1.15% (Caulerpa prolifera)- 21.38±1.53% (Ericaria amentacea), 1.74±0.19% (Caulerpa prolifera)- 5.83±0.68% (Ericaria amentacea), 5.56±0.06% (Chaetomorpha linum)- 11.45±0.53% (Sargassum vulgare), respec-tively. Ash, lipid and protein values of Angiosperms/Seagrass (Halophila stipulacea) were determined as 14.56±2.08%, 3.16±0.48% and 8.11±0.07%, respectively. Protein value of Angiosperms/Seagrass (Halophila stipulacea) was higher than those of (GMA (Chaetomorpha linum and Caulerpa prolifera) but not RMA(Pterocladiella capillacea) and BMA (Sargassum vulgare and Ericaria amentacea)). Lipid value of Angio-sperms/Seagrass (Halophila stipulacea) was similar to RMA(Pterocladiella capillacea). In conclusion, the information of the biochemical compositions of five different macroalgae and Angiosperms/Seagrass (Halophila stipulacea) are important for the evaluation of potential sources for commercial and human consumption. In addition, biochemical compositions of tested macroalgae and seagrass could make important contributions to feed formulations and functional foods in future.
- 10 August 2022
- Published by Springer Nature in Medical & Biological Engineering & Computing
- Vol. 60 (10) , 2877-2897
Identifying the tumor location-associated candidate genes in development of new drugs for colorectal cancer using machine-learning-based approach
Numerous studies have been conducted to elucidate the relation of tumor proximity to cancer prognosis and treatment efficacy in colorectal cancer. However, the molecular pathways and prognoses of left- and right-sided colorectal cancers are different, and this difference has not been fully investigated at the genomic level. In this study, a set of data science approaches, including six feature selection methods and three classification models, were used in predicting tumor location from gene expression profiles. Specificity, sensitivity, accuracy, and Mathew’s correlation coefficient (MCC) evaluation metrics were used to evaluate the classification ability. Gene ontology enrichment analysis was applied by the Gene Ontology PANTHER Classification System. For the most significant 50 genes, protein–protein interactions and drug-gene interactions were analyzed using the GeneMANIA, CytoScape, CytoHubba, MCODE, and DGIdb databases. The highest classification accuracy (90%) is achieved with the most significant 200 genes when the ensemble-decision tree classification model is used with the ReliefF feature selection method. Molecular pathways and drug interactions are investigated for the most significant 50 genes. It is concluded that a machine-learning-based approach could be useful to discover the significant genes that may have an important role in the development of new therapies and drugs for colorectal cancer. Graphical abstract
- 10 August 2022
- Published by Springer Nature in Medical & Biological Engineering & Computing
- Vol. 60 (10) , 2877-2897
Identifying the tumor location-associated candidate genes in development of new drugs for colorectal cancer using machine-learning-based approach
Numerous studies have been conducted to elucidate the relation of tumor proximity to cancer prognosis and treatment efficacy in colorectal cancer. However, the molecular pathways and prognoses of left- and right-sided colorectal cancers are different, and this difference has not been fully investigated at the genomic level. In this study, a set of data science approaches, including six feature selection methods and three classification models, were used in predicting tumor location from gene expression profiles. Specificity, sensitivity, accuracy, and Mathew’s correlation coefficient (MCC) evaluation metrics were used to evaluate the classification ability. Gene ontology enrichment analysis was applied by the Gene Ontology PANTHER Classification System. For the most significant 50 genes, protein–protein interactions and drug-gene interactions were analyzed using the GeneMANIA, CytoScape, CytoHubba, MCODE, and DGIdb databases. The highest classification accuracy (90%) is achieved with the most significant 200 genes when the ensemble-decision tree classification model is used with the ReliefF feature selection method. Molecular pathways and drug interactions are investigated for the most significant 50 genes. It is concluded that a machine-learning-based approach could be useful to discover the significant genes that may have an important role in the development of new therapies and drugs for colorectal cancer. Graphical abstract
- Open Access
- 1 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 4748447
Ginger for Healthy Ageing: A Systematic Review on Current Evidence of Its Antioxidant, Anti‐Inflammatory, and Anticancer Properties
The world’s population is ageing at an accelerated pace. Ageing is a natural, physiological but highly complex and multifactorial process that all species in the Tree of Life experience over time. Physical and mental disabilities, and age‐related diseases, would increase along with the increasing life expectancy. Ginger (Zingiber officinale) is a plant that belongs to the Zingiberaceae family, native to Southeast Asia. For hundreds of years, ginger has been consumed in various ways by the natives of Asian countries, both as culinary and medicinal herb for the treatment of many diseases. Mounting evidence suggests that ginger can promote healthy ageing, reduce morbidity, and prolong healthy lifespan. Ginger, a well‐known natural product, has been demonstrated to possess antioxidant, anti‐inflammatory, anticancer, and antimicrobial properties, as well as an outstanding antiviral activity due to a high concentration of antiviral compounds. In this review, the current evidence on the potential role of ginger and its active compounds in the prevention of ageing is discussed.
- 1 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 4748447
Open AccessGinger for Healthy Ageing: A Systematic Review on Current Evidence of Its Antioxidant, Anti‐Inflammatory, and Anticancer Properties
The world’s population is ageing at an accelerated pace. Ageing is a natural, physiological but highly complex and multifactorial process that all species in the Tree of Life experience over time. Physical and mental disabilities, and age‐related diseases, would increase along with the increasing life expectancy. Ginger (Zingiber officinale) is a plant that belongs to the Zingiberaceae family, native to Southeast Asia. For hundreds of years, ginger has been consumed in various ways by the natives of Asian countries, both as culinary and medicinal herb for the treatment of many diseases. Mounting evidence suggests that ginger can promote healthy ageing, reduce morbidity, and prolong healthy lifespan. Ginger, a well‐known natural product, has been demonstrated to possess antioxidant, anti‐inflammatory, anticancer, and antimicrobial properties, as well as an outstanding antiviral activity due to a high concentration of antiviral compounds. In this review, the current evidence on the potential role of ginger and its active compounds in the prevention of ageing is discussed.
- 25 September 2021
- Published by Springer Nature
- p. 591-631
Omega-3 Polyunsaturated Fatty Acids and Cancer
- 25 September 2021
- Published by Springer Nature
- p. 591-631
Omega-3 Polyunsaturated Fatty Acids and Cancer
- 13 April 2021
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 17 (3) , 1074-1077
Targeting the PANoptosome with miRNA Loaded Mesenchymal Stem Cell Derived Extracellular Vesicles; a New Path to Fight Against the Covid-19?
- 13 April 2021
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 17 (3) , 1074-1077
Targeting the PANoptosome with miRNA Loaded Mesenchymal Stem Cell Derived Extracellular Vesicles; a New Path to Fight Against the Covid-19?
- 4 January 2021
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 17 (2) , 471-501
Preclinical Experimental Applications of miRNA Loaded BMSC Extracellular Vesicles
Bone marrow mesenchymal stem cells have been investigated for many years, especially for tissue regeneration, and have inherent limitations. One of the rapidly developing fields in the scientific world in recent years is extracellular vesicles. Especially, bone marrow mesenchymal stem cell originated extracellular vesicles are known to have positive contributions in tissue regeneration, and these extracellular vesicles have also been used as gene transfer systems for cellular therapy. Through gene expression analysis and bioinformatics tools, it is possible to determine which genes have changed in the targeted tissue or cell and which miRNAs that can correct this gene expression disorder. This approach connecting the stem cell, extracellular vesicles, epigenetics regulation and bioinformatics fields is one of the promising areas for the treatment of diseases in the future. With this review, it is aimed to present the studies carried out for the use of bone marrow stem cell-derived extracellular vesicles loaded with targeted miRNAs in different in vivo and in vitro human disease models and to discuss recent developments in this field.
- 4 January 2021
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 17 (2) , 471-501
Preclinical Experimental Applications of miRNA Loaded BMSC Extracellular Vesicles
Bone marrow mesenchymal stem cells have been investigated for many years, especially for tissue regeneration, and have inherent limitations. One of the rapidly developing fields in the scientific world in recent years is extracellular vesicles. Especially, bone marrow mesenchymal stem cell originated extracellular vesicles are known to have positive contributions in tissue regeneration, and these extracellular vesicles have also been used as gene transfer systems for cellular therapy. Through gene expression analysis and bioinformatics tools, it is possible to determine which genes have changed in the targeted tissue or cell and which miRNAs that can correct this gene expression disorder. This approach connecting the stem cell, extracellular vesicles, epigenetics regulation and bioinformatics fields is one of the promising areas for the treatment of diseases in the future. With this review, it is aimed to present the studies carried out for the use of bone marrow stem cell-derived extracellular vesicles loaded with targeted miRNAs in different in vivo and in vitro human disease models and to discuss recent developments in this field.
- 5 April 2015
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 167 (8) , 1836-1841
A familial interstitial 4q35 deletion with no discernible clinical effects
Small deletions on the long arm of distal chromosome 4 do not appear to result in gross congenital malformations, with the most frequently reported clinical findings including mild to moderate intellectual disability, learning disabilities and minor dysmorphic features. Here we report on a cytogenetically detectable familial interstitial chromosome 4 long arm deletion with no discernible phenotypic effects in a mother and her two daughters. The karyotypes of the mother and her two daughters were: 46,XX,del(4)(q35.1q35.2). Based on the results of FISH analyses using whole chromosome specific and subtelomeric probes, the karyotype was designated as: 46,XX,del(4)(q35.1q35.2). ish del(4)(q35‐qter)(WCP4+, 36P21+, dJ963K6‐). Array‐CGH analysis showed an interstitial deletion encompassing 5.75 Mb in the 4q35.1–q35.2 genomic region (chr4:184,717,878–190,469,337; hg19). This is the first report on a cytogenetically detectable familial interstitial chromosome 4 long arm deletion in which there are no discernible phenotypic effects. Both our findings and a review of the literature suggest that more detailed molecular analyses are needed in cases with distal chromosome 4 long arm deletions especially those with breakpoints in the 4q35 region to establish a more precise genotype–phenotype correlation.
- 5 April 2015
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 167 (8) , 1836-1841
A familial interstitial 4q35 deletion with no discernible clinical effects
Small deletions on the long arm of distal chromosome 4 do not appear to result in gross congenital malformations, with the most frequently reported clinical findings including mild to moderate intellectual disability, learning disabilities and minor dysmorphic features. Here we report on a cytogenetically detectable familial interstitial chromosome 4 long arm deletion with no discernible phenotypic effects in a mother and her two daughters. The karyotypes of the mother and her two daughters were: 46,XX,del(4)(q35.1q35.2). Based on the results of FISH analyses using whole chromosome specific and subtelomeric probes, the karyotype was designated as: 46,XX,del(4)(q35.1q35.2). ish del(4)(q35‐qter)(WCP4+, 36P21+, dJ963K6‐). Array‐CGH analysis showed an interstitial deletion encompassing 5.75 Mb in the 4q35.1–q35.2 genomic region (chr4:184,717,878–190,469,337; hg19). This is the first report on a cytogenetically detectable familial interstitial chromosome 4 long arm deletion in which there are no discernible phenotypic effects. Both our findings and a review of the literature suggest that more detailed molecular analyses are needed in cases with distal chromosome 4 long arm deletions especially those with breakpoints in the 4q35 region to establish a more precise genotype–phenotype correlation.
- 10 September 2009
- Published by Springer Nature in Medical Oncology
- Vol. 27 (3) , 853-860
Evaluation of PTEN and Mcl-1 expressions in NSCLC expressing wild-type or mutated EGFR
Signaling pathways activated by epidermal growth factor receptors (EGFRs) are important in lung carcinogenesis. New treatment strategies with EGFR-targeting drugs provided improvements in management of lung cancer. However, molecular mechanisms underlying resistance to these drugs need to be evaluated. Surgically resected samples were obtained from 50 patients with non-small-cell-lung cancer. PTEN, Mcl-1 and EGFR protein expression levels were evaluated by Western-blot. Direct sequencing was performed to investigate EGFR tyrosine kinase domain mutations. We detected c.2235-2249 (pGlu746-Ala750del) mutation in exon 19 in two patients with adenocarcinoma histology. Elevated expression levels of both Mcl-1 isoforms (Mcl-1S and Mcl-1XL) and EGFR proteins were found in 15 (30%) and 23 (46%) of the cases, respectively. Reduced PTEN protein expression levels were observed in 17 (34%) of the cases. PTEN expression level was reduced in 26% of cases that showed increased EGFR expression. Also, increased expression of Mcl-1 protein was observed in 26% of cases with EGFR overexpression. One of the cases harboring pGlu746-Ala750del mutation had increased levels of Mcl-1 and decreased PTEN expression levels. Our results indicate that, in addition to lack of PTEN expression, elevated levels of the Mcl-1 protein might be one of the important intrinsic mechanisms protecting non-small–cell-lung cancer cells from apoptosis induced by several compounds. Therefore, EGFR mutations in conjunction with evaluation of Mcl-1 and PTEN expression levels in large cohorts might provide important clues for improvements of new treatment strategies in non-small–cell-lung cancer management.
- 10 September 2009
- Published by Springer Nature in Medical Oncology
- Vol. 27 (3) , 853-860
Evaluation of PTEN and Mcl-1 expressions in NSCLC expressing wild-type or mutated EGFR
Signaling pathways activated by epidermal growth factor receptors (EGFRs) are important in lung carcinogenesis. New treatment strategies with EGFR-targeting drugs provided improvements in management of lung cancer. However, molecular mechanisms underlying resistance to these drugs need to be evaluated. Surgically resected samples were obtained from 50 patients with non-small-cell-lung cancer. PTEN, Mcl-1 and EGFR protein expression levels were evaluated by Western-blot. Direct sequencing was performed to investigate EGFR tyrosine kinase domain mutations. We detected c.2235-2249 (pGlu746-Ala750del) mutation in exon 19 in two patients with adenocarcinoma histology. Elevated expression levels of both Mcl-1 isoforms (Mcl-1S and Mcl-1XL) and EGFR proteins were found in 15 (30%) and 23 (46%) of the cases, respectively. Reduced PTEN protein expression levels were observed in 17 (34%) of the cases. PTEN expression level was reduced in 26% of cases that showed increased EGFR expression. Also, increased expression of Mcl-1 protein was observed in 26% of cases with EGFR overexpression. One of the cases harboring pGlu746-Ala750del mutation had increased levels of Mcl-1 and decreased PTEN expression levels. Our results indicate that, in addition to lack of PTEN expression, elevated levels of the Mcl-1 protein might be one of the important intrinsic mechanisms protecting non-small–cell-lung cancer cells from apoptosis induced by several compounds. Therefore, EGFR mutations in conjunction with evaluation of Mcl-1 and PTEN expression levels in large cohorts might provide important clues for improvements of new treatment strategies in non-small–cell-lung cancer management.